Logo Université Laval Logo Université Laval
International Chair on Cardiometabolic Risk
My Healthy Waist

Documentation centre

1969-1980 of 2541 results
Page 165 of 212
Key Publications February 1, 2017

Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.

Lancet. 2016;388:1459-1544

GBD 2015 Mortality and Causes of Death Collaborators
Cancer Cardiovascular Disease Epidemiology
Key Publications January 31, 2017

Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.

J Lipid Res. 2016;57:1953-1975

Nordestgaard BG, Langsted A
Cardiovascular Disease Genetics Lipids/Lipoproteins
Key Publications January 31, 2017

Genetic analysis of emerging risk factors in coronary artery disease.

Atherosclerosis. 2016;254:35-41

van Iperen EP, Sivapalaratnam S, Holmes MV, Hovingh GK, Zwinderman AH, Asselbergs FW
Cardiovascular Disease Genetics Lipids/Lipoproteins
Key Publications January 31, 2017

A whole-grain diet reduces cardiovascular risk factors in overweight and obese adults: A randomized controlled trial.

J Nutr. 2016;146:2244-2251

Kirwan JP, Malin SK, Scelsi AR, Kullman EL, Navaneethan SD, Pagadala MR, Haus JM, Filion J, Godin JP, Kochhar S, Ross AB
Cardiovascular Disease Nutrition Obesity
Key Publications January 30, 2017

Sleep duration and quality: Impact on lifestyle behaviors and cardiometabolic health: A scientific statement from the American Heart Association.

Circulation. 2016;134:e367-e386

St-Onge MP, Grandner MA, Brown D, Conroy MB, Jean-Louis G, Coons M, Bhatt DL; American Heart Association Obesity, Behavior Change, Diabetes, and Nutrition Committees of the Council on Lifestyle and Cardiometabolic Health et al.
Cardiovascular Disease Diabetes Obesity
Key Publications January 30, 2017

Should patients with cardiovascular risk factors receive intensive treatment of hypertension to <120/80 mmHg target? An antagonist view from the HOPE-3 trial (Heart Outcomes Evaluation-3).

Circulation. 2016;134:1311-1313

Lonn EM, Yusuf S
Cardiovascular Disease Clinical Trials Hypertension
Key Publications January 27, 2017

Should patients with cardiovascular risk factors receive intensive treatment of hypertension to <120/80 mmHg target? A protagonist view from the SPRINT trial (Systolic Blood Pressure Intervention Trial).

Circulation. 2016;134:1308-1310

Oparil S, Lewis CE
Cardiovascular Disease Clinical Trials Hypertension
Key Publications January 27, 2017

High-density lipoprotein cholesterol and cause-specific mortality in individuals without previous cardiovascular conditions: The CANHEART study.

J Am Coll Cardiol. 2016;68:2073-2083

Ko DT, Alter DA, Guo H, Koh M, Lau G, Austin PC, Booth GL, Hogg W, Jackevicius CA, Lee DS, Wijeysundera HC, Wilkins JT, Tu JV
Cardiovascular Disease Epidemiology Lipids/Lipoproteins
Key Publications January 27, 2017

Will big data shine light at the end of the tunnel for HDL?

J Am Coll Cardiol. 2016;68:2084-2085

Nicholls SJ, Psaltis PJ
Cardiovascular Disease Epidemiology Lipids/Lipoproteins
Key Publications January 26, 2017

Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study.

Lancet. 2016: S0140-6736:31326-5

Vidal-Petiot E, Ford I, Greenlaw N, Ferrari R, Fox KM, Tardif JC, Tendera M, Tavazzi L, Bhatt DL, Steg PG; CLARIFY Investigators
Cardiovascular Disease Epidemiology Hypertension
Key Publications January 25, 2017

Plasma levels of fatty acid-binding protein 4, retinol-binding protein 4, high-molecular-weight adiponectin, and cardiovascular mortality among men with type 2 diabetes: A 22-year prospective study.

Arterioscler Thromb Vasc Biol. 2016;36:2259-2267

Liu G, Ding M, Chiuve SE, Rimm EB, Franks PW, Meigs JB, Hu FB, Sun Q
Adipokines Cardiovascular Disease Diabetes
Key Publications January 25, 2017

Non-HDL cholesterol and triglycerides: Implications for coronary atheroma progression and clinical events.

Arterioscler Thromb Vasc Biol. 2016;36:2220-2228

Puri R, Nissen SE, Shao M, Elshazly MB, Kataoka Y, Kapadia SR, Tuzcu EM, Nicholls SJ
Cardiovascular Disease Clinical Cardiology Lipids/Lipoproteins
of 212